Supplemental Guarantor Information (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | $322.50 | $325.70 | ' |
Operating costs and expenses | 265.6 | 306.5 | ' |
Operating (loss) income | 56.9 | 19.2 | ' |
Interest expense (income), net | 40.3 | 47.9 | ' |
Other (income) expense, net | 0.6 | -0.3 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 16.5 | -30.3 | ' |
Income tax (benefit) expense | 9.5 | 6.4 | ' |
Net income (loss) | 7 | -36.7 | ' |
Total comprehensive income (loss) | 8.8 | -34.1 | ' |
Preferred stock dividends | 2.6 | 2.6 | ' |
Net income (loss) applicable to common shareowners | 4.4 | -39.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 4.2 | 5.1 | ' |
Other current assets | 2.6 | ' | 1.6 |
Total current assets | 273.4 | ' | 251.1 |
Property, plant and equipment, net | 892.2 | ' | 902.8 |
Investment in CyrusOne | 462.2 | ' | 471 |
Other noncurrent assets | 34.8 | ' | 36.6 |
Total assets | 2,101.50 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.6 |
Accounts payable | 111.3 | ' | 89.4 |
Other current liabilities | 31.8 | ' | 36.8 |
Total current liabilities | 265.7 | ' | 254.3 |
Long-term debt, less current portion | 2,244.10 | ' | 2,252.60 |
Other noncurrent liabilities | 68.8 | ' | 74.4 |
Total liabilities | 2,772.20 | ' | 2,784 |
Shareowners' (deficit) equity | -670.7 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,101.50 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 37.8 | 42.3 | ' |
Capital expenditures | -34.3 | -50.9 | ' |
Proceeds from sale of assets | 1.9 | 0.8 | ' |
Dividends received from CyrusOne | 7.1 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | 0 | 12.2 | ' |
Cash flows used in investing activities | -25.3 | -61.9 | ' |
(Decrease) increase in receivables facility, net | -4.1 | 2 | ' |
Repayment of debt | -5.2 | -3.1 | ' |
Proceeds from exercise of options and warrants | 0.6 | 6.6 | ' |
Other financing activities | -1.7 | -2.3 | ' |
Cash flows provided by (used in) financing activities | -12.9 | 1.1 | ' |
(Decrease) increase in cash and cash equivalents | -0.4 | -18.5 | ' |
Cash and cash equivalents at beginning of period | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 4.2 | 5.1 | ' |
Notes guaranteed by parent [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 322.5 | 325.7 | ' |
Operating costs and expenses | 265.6 | 306.5 | ' |
Operating (loss) income | 56.9 | 19.2 | ' |
Interest expense (income), net | 40.3 | 47.9 | ' |
Other (income) expense, net | 0.1 | 1.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 16.5 | -30.3 | ' |
Income tax (benefit) expense | 9.5 | 6.4 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | ' |
Net income (loss) | 7 | -36.7 | ' |
Other comprehensive income (loss) | 1.8 | 2.6 | ' |
Total comprehensive income (loss) | 8.8 | -34.1 | ' |
Preferred stock dividends | 2.6 | 2.6 | ' |
Net income (loss) applicable to common shareowners | 4.4 | -39.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 4.2 | 5.1 | ' |
Receivables, net | 177 | ' | 154.8 |
Other current assets | 92.2 | ' | 91.7 |
Total current assets | 273.4 | ' | 251.1 |
Property, plant and equipment, net | 892.2 | ' | 902.8 |
Investment in CyrusOne | 462.2 | ' | 471 |
Goodwill and intangibles, net | 105.6 | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 |
Other noncurrent assets | 368.1 | ' | 376.3 |
Total assets | 2,101.50 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.6 |
Accounts payable | 112 | ' | 89.9 |
Other current liabilities | 141.6 | ' | 151.8 |
Total current liabilities | 265.7 | ' | 254.3 |
Long-term debt, less current portion | 2,244.10 | ' | 2,252.60 |
Other noncurrent liabilities | 262.4 | ' | 277.1 |
Intercompany payables | 0 | ' | 0 |
Total liabilities | 2,772.20 | ' | 2,784 |
Shareowners' (deficit) equity | -670.7 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,101.50 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 37.8 | 42.3 | ' |
Capital expenditures | -34.3 | -50.9 | ' |
Proceeds from sale of assets | 1.9 | 0.8 | ' |
Dividends received from CyrusOne | 7.1 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | -12.2 | ' |
Other investing activities | ' | 0.4 | ' |
Cash flows used in investing activities | -25.3 | -61.9 | ' |
Funding between Parent and subsidiaries, net | 0 | 0 | ' |
(Decrease) increase in receivables facility, net | -4.1 | 2 | ' |
Repayment of debt | -5.2 | -3.1 | ' |
Proceeds from exercise of options and warrants | 0.6 | 6.6 | ' |
Other financing activities | -4.2 | -4.4 | ' |
Cash flows provided by (used in) financing activities | -12.9 | 1.1 | ' |
(Decrease) increase in cash and cash equivalents | -0.4 | -18.5 | ' |
Cash and cash equivalents at beginning of period | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 4.2 | 5.1 | ' |
Notes guaranteed by parent [Member] | Parent Company [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 0 | 0 | ' |
Operating costs and expenses | 6.1 | 36.1 | ' |
Operating (loss) income | -6.1 | -36.1 | ' |
Interest expense (income), net | 37.1 | 35.8 | ' |
Other (income) expense, net | -0.3 | -0.4 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | -42.9 | -71.5 | ' |
Income tax (benefit) expense | -11.5 | -20.1 | ' |
Equity in earnings of subsidiaries, net of tax | 38.4 | 14.7 | ' |
Net income (loss) | 7 | -36.7 | ' |
Other comprehensive income (loss) | 1.8 | 2.8 | ' |
Total comprehensive income (loss) | 8.8 | -33.9 | ' |
Preferred stock dividends | 2.6 | 2.6 | ' |
Net income (loss) applicable to common shareowners | 4.4 | -39.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 1.9 | 2.9 | ' |
Receivables, net | 1.9 | ' | 2.6 |
Other current assets | 20.4 | ' | 4.4 |
Total current assets | 24.2 | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,437.60 | ' | 1,406.60 |
Other noncurrent assets | 332.8 | ' | 359.1 |
Total assets | 1,794.70 | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 |
Accounts payable | 0.5 | ' | 1.5 |
Other current liabilities | 66 | ' | 67.7 |
Total current liabilities | 71.9 | ' | 74.6 |
Long-term debt, less current portion | 1,912.70 | ' | 1,916.10 |
Other noncurrent liabilities | 204.8 | ' | 214.5 |
Intercompany payables | 276 | ' | 246.4 |
Total liabilities | 2,465.40 | ' | 2,451.60 |
Shareowners' (deficit) equity | -670.7 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,794.70 | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | -29.9 | -27.5 | ' |
Capital expenditures | 0 | 0 | ' |
Proceeds from sale of assets | 0 | 0 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | 37.1 | 24.4 | ' |
(Decrease) increase in receivables facility, net | -2.5 | 0 | ' |
Repayment of debt | -1.3 | 0 | ' |
Proceeds from exercise of options and warrants | 0.6 | 6.6 | ' |
Other financing activities | -4.2 | -4.4 | ' |
Cash flows provided by (used in) financing activities | 29.7 | 26.6 | ' |
(Decrease) increase in cash and cash equivalents | -0.2 | -0.9 | ' |
Cash and cash equivalents at beginning of period | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 1.9 | 2.9 | ' |
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 173.6 | 180.5 | ' |
Operating costs and expenses | 161 | 173.4 | ' |
Operating (loss) income | 12.6 | 7.1 | ' |
Interest expense (income), net | 4 | 7.6 | ' |
Other (income) expense, net | -1.5 | 0.3 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 10.1 | -0.8 | ' |
Income tax (benefit) expense | 2.9 | 10 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | ' |
Net income (loss) | 7.2 | -10.8 | ' |
Other comprehensive income (loss) | 0 | -0.2 | ' |
Total comprehensive income (loss) | 7.2 | -11 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 7.2 | -10.8 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 1.5 | 0.9 | ' |
Receivables, net | 175.1 | ' | 152.2 |
Other current assets | 48.8 | ' | 63.9 |
Total current assets | 225.4 | ' | 216.8 |
Property, plant and equipment, net | 183 | ' | 196.2 |
Investment in CyrusOne | 462.2 | ' | 471 |
Goodwill and intangibles, net | 103.4 | ' | 103.8 |
Investments in and advances to subsidiaries | 0 | ' | 0 |
Other noncurrent assets | 193.4 | ' | 178.9 |
Total assets | 1,167.40 | ' | 1,166.70 |
Current portion of long-term debt | 3 | ' | 3.3 |
Accounts payable | 56.4 | ' | 42.5 |
Other current liabilities | 33.5 | ' | 34.6 |
Total current liabilities | 92.9 | ' | 80.4 |
Long-term debt, less current portion | 190.9 | ' | 194.7 |
Other noncurrent liabilities | 50.7 | ' | 59 |
Intercompany payables | 192.6 | ' | 199.7 |
Total liabilities | 527.1 | ' | 533.8 |
Shareowners' (deficit) equity | 640.3 | ' | 632.9 |
Total liabilities and shareowners' equity (deficit) | 1,167.40 | ' | 1,166.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 15.2 | 27.6 | ' |
Capital expenditures | -11.7 | -18.7 | ' |
Proceeds from sale of assets | 1.8 | 0 | ' |
Dividends received from CyrusOne | 7.1 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | -12.2 | ' |
Other investing activities | ' | 0.4 | ' |
Cash flows used in investing activities | -2.8 | -30.5 | ' |
Funding between Parent and subsidiaries, net | -7.1 | -13.8 | ' |
(Decrease) increase in receivables facility, net | -1.6 | 2 | ' |
Repayment of debt | -2.9 | -2.3 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | -11.6 | -14.1 | ' |
(Decrease) increase in cash and cash equivalents | 0.8 | -17 | ' |
Cash and cash equivalents at beginning of period | 0.7 | 17.9 | ' |
Cash and cash equivalents at end of period | 1.5 | 0.9 | ' |
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 163.3 | 159.3 | ' |
Operating costs and expenses | 112.9 | 111.1 | ' |
Operating (loss) income | 50.4 | 48.2 | ' |
Interest expense (income), net | -0.8 | 4.5 | ' |
Other (income) expense, net | 1.9 | 1.7 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 49.3 | 42 | ' |
Income tax (benefit) expense | 18.1 | 16.5 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | ' |
Net income (loss) | 31.2 | 25.5 | ' |
Other comprehensive income (loss) | 0 | 0 | ' |
Total comprehensive income (loss) | 31.2 | 25.5 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 31.2 | 25.5 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 0.8 | 1.3 | ' |
Receivables, net | 0 | ' | 0 |
Other current assets | 23.6 | ' | 24.1 |
Total current assets | 24.4 | ' | 25.9 |
Property, plant and equipment, net | 709.1 | ' | 706.5 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.3 |
Investments in and advances to subsidiaries | 277.7 | ' | 247.7 |
Other noncurrent assets | 5.8 | ' | 6.1 |
Total assets | 1,019.20 | ' | 988.5 |
Current portion of long-term debt | 3.7 | ' | 3.9 |
Accounts payable | 55.1 | ' | 45.9 |
Other current liabilities | 42.1 | ' | 49.4 |
Total current liabilities | 100.9 | ' | 99.2 |
Long-term debt, less current portion | 140.5 | ' | 141.8 |
Other noncurrent liabilities | 171.4 | ' | 172.2 |
Intercompany payables | 0 | ' | 0 |
Total liabilities | 412.8 | ' | 413.2 |
Shareowners' (deficit) equity | 606.4 | ' | 575.3 |
Total liabilities and shareowners' equity (deficit) | 1,019.20 | ' | 988.5 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 52.5 | 42.2 | ' |
Capital expenditures | -22.6 | -32.2 | ' |
Proceeds from sale of assets | 0.1 | 0.8 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | -22.5 | -31.4 | ' |
Funding between Parent and subsidiaries, net | -30 | -10.6 | ' |
(Decrease) increase in receivables facility, net | 0 | 0 | ' |
Repayment of debt | -1 | -0.8 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | -31 | -11.4 | ' |
(Decrease) increase in cash and cash equivalents | -1 | -0.6 | ' |
Cash and cash equivalents at beginning of period | 1.8 | 1.9 | ' |
Cash and cash equivalents at end of period | 0.8 | 1.3 | ' |
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | -14.4 | -14.1 | ' |
Operating costs and expenses | -14.4 | -14.1 | ' |
Operating (loss) income | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 0 | 0 | ' |
Income tax (benefit) expense | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -38.4 | -14.7 | ' |
Net income (loss) | -38.4 | -14.7 | ' |
Other comprehensive income (loss) | 0 | 0 | ' |
Total comprehensive income (loss) | -38.4 | -14.7 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -38.4 | -14.7 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 |
Other current assets | -0.6 | ' | -0.7 |
Total current assets | -0.6 | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 |
Investments in and advances to subsidiaries | -1,715.30 | ' | -1,654.30 |
Other noncurrent assets | -163.9 | ' | -167.8 |
Total assets | -1,879.80 | ' | -1,822.80 |
Current portion of long-term debt | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 |
Other current liabilities | 0 | ' | 0.1 |
Total current liabilities | 0 | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 |
Other noncurrent liabilities | -164.5 | ' | -168.6 |
Intercompany payables | -468.6 | ' | -446.1 |
Total liabilities | -633.1 | ' | -614.6 |
Shareowners' (deficit) equity | -1,246.70 | ' | -1,208.20 |
Total liabilities and shareowners' equity (deficit) | -1,879.80 | ' | -1,822.80 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 0 | 0 | ' |
Capital expenditures | 0 | 0 | ' |
Proceeds from sale of assets | 0 | 0 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | 0 | 0 | ' |
(Decrease) increase in receivables facility, net | 0 | 0 | ' |
Repayment of debt | 0 | 0 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | 0 | 0 | ' |
(Decrease) increase in cash and cash equivalents | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | ' |
Notes guaranteed by subsidiaries [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 322.5 | 325.7 | ' |
Operating costs and expenses | 265.6 | 306.5 | ' |
Operating (loss) income | 56.9 | 19.2 | ' |
Interest expense (income), net | 40.3 | 47.9 | ' |
Other (income) expense, net | 0.1 | 1.6 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 16.5 | -30.3 | ' |
Income tax (benefit) expense | 9.5 | 6.4 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | ' |
Net income (loss) | 7 | -36.7 | ' |
Other comprehensive income (loss) | 1.8 | 2.6 | ' |
Total comprehensive income (loss) | 8.8 | -34.1 | ' |
Preferred stock dividends | 2.6 | 2.6 | ' |
Net income (loss) applicable to common shareowners | 4.4 | -39.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 4.2 | 5.1 | ' |
Receivables, net | 177 | ' | 154.8 |
Other current assets | 92.2 | ' | 91.7 |
Total current assets | 273.4 | ' | 251.1 |
Property, plant and equipment, net | 892.2 | ' | 902.8 |
Investment in CyrusOne | 462.2 | ' | 471 |
Goodwill and intangibles, net | 105.6 | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 |
Other noncurrent assets | 368.1 | ' | 376.3 |
Total assets | 2,101.50 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.6 |
Accounts payable | 112 | ' | 89.9 |
Other current liabilities | 141.6 | ' | 151.8 |
Total current liabilities | 265.7 | ' | 254.3 |
Long-term debt, less current portion | 2,244.10 | ' | 2,252.60 |
Other noncurrent liabilities | 262.4 | ' | 277.1 |
Intercompany payables | 0 | ' | 0 |
Total liabilities | 2,772.20 | ' | 2,784 |
Shareowners' (deficit) equity | -670.7 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,101.50 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 37.8 | 42.3 | ' |
Capital expenditures | -34.3 | -50.9 | ' |
Proceeds from sale of assets | 1.9 | 0.8 | ' |
Dividends received from CyrusOne | 7.1 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | -12.2 | ' |
Other investing activities | ' | 0.4 | ' |
Cash flows used in investing activities | -25.3 | -61.9 | ' |
Funding between Parent and subsidiaries, net | 0 | 0 | ' |
(Decrease) increase in receivables facility, net | -4.1 | 2 | ' |
Repayment of debt | -5.2 | -3.1 | ' |
Proceeds from exercise of options and warrants | 0.6 | 6.6 | ' |
Other financing activities | -4.2 | -4.4 | ' |
Cash flows provided by (used in) financing activities | -12.9 | 1.1 | ' |
(Decrease) increase in cash and cash equivalents | -0.4 | -18.5 | ' |
Cash and cash equivalents at beginning of period | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 4.2 | 5.1 | ' |
Notes guaranteed by subsidiaries [Member] | Parent Company [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 0 | 0 | ' |
Operating costs and expenses | 6.1 | 36.1 | ' |
Operating (loss) income | -6.1 | -36.1 | ' |
Interest expense (income), net | 37.1 | 35.8 | ' |
Other (income) expense, net | -0.3 | -0.4 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | -42.9 | -71.5 | ' |
Income tax (benefit) expense | -11.5 | -20.1 | ' |
Equity in earnings of subsidiaries, net of tax | 38.4 | 14.7 | ' |
Net income (loss) | 7 | -36.7 | ' |
Other comprehensive income (loss) | 1.8 | 2.8 | ' |
Total comprehensive income (loss) | 8.8 | -33.9 | ' |
Preferred stock dividends | 2.6 | 2.6 | ' |
Net income (loss) applicable to common shareowners | 4.4 | -39.3 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 1.9 | 2.9 | ' |
Receivables, net | 1.9 | ' | 2.6 |
Other current assets | 20.4 | ' | 4.4 |
Total current assets | 24.2 | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,437.60 | ' | 1,406.60 |
Other noncurrent assets | 332.8 | ' | 359.1 |
Total assets | 1,794.70 | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 |
Accounts payable | 0.5 | ' | 1.5 |
Other current liabilities | 66 | ' | 67.7 |
Total current liabilities | 71.9 | ' | 74.6 |
Long-term debt, less current portion | 1,912.70 | ' | 1,916.10 |
Other noncurrent liabilities | 204.8 | ' | 214.5 |
Intercompany payables | 276 | ' | 246.4 |
Total liabilities | 2,465.40 | ' | 2,451.60 |
Shareowners' (deficit) equity | -670.7 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,794.70 | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | -29.9 | -27.5 | ' |
Capital expenditures | 0 | 0 | ' |
Proceeds from sale of assets | 0 | 0 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | 37.1 | 24.4 | ' |
(Decrease) increase in receivables facility, net | -2.5 | 0 | ' |
Repayment of debt | -1.3 | 0 | ' |
Proceeds from exercise of options and warrants | 0.6 | 6.6 | ' |
Other financing activities | -4.2 | -4.4 | ' |
Cash flows provided by (used in) financing activities | 29.7 | 26.6 | ' |
(Decrease) increase in cash and cash equivalents | -0.2 | -0.9 | ' |
Cash and cash equivalents at beginning of period | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 1.9 | 2.9 | ' |
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 187.1 | 175.7 | ' |
Operating costs and expenses | 172.9 | 170.1 | ' |
Operating (loss) income | 14.2 | 5.6 | ' |
Interest expense (income), net | 3.6 | 3.9 | ' |
Other (income) expense, net | 3.5 | 4.7 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 7.1 | -3 | ' |
Income tax (benefit) expense | 2.3 | 9.5 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0.7 | ' |
Net income (loss) | 4.8 | -11.8 | ' |
Other comprehensive income (loss) | 0 | 0 | ' |
Total comprehensive income (loss) | 4.8 | -11.8 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 4.8 | -11.8 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 1.1 | 0.4 | ' |
Receivables, net | 9.4 | ' | 7.2 |
Other current assets | 45.1 | ' | 60.7 |
Total current assets | 55.6 | ' | 68.2 |
Property, plant and equipment, net | 182.6 | ' | 194.1 |
Investment in CyrusOne | 462.2 | ' | 471 |
Goodwill and intangibles, net | 103.4 | ' | 103.8 |
Investments in and advances to subsidiaries | -1.7 | ' | -1.6 |
Other noncurrent assets | 194.6 | ' | 179.9 |
Total assets | 996.7 | ' | 1,015.40 |
Current portion of long-term debt | 3 | ' | 3 |
Accounts payable | 79.7 | ' | 72.3 |
Other current liabilities | 35.3 | ' | 36.9 |
Total current liabilities | 118 | ' | 112.2 |
Long-term debt, less current portion | 86.3 | ' | 87 |
Other noncurrent liabilities | 53.1 | ' | 61.3 |
Intercompany payables | 129.4 | ' | 149.9 |
Total liabilities | 386.8 | ' | 410.4 |
Shareowners' (deficit) equity | 609.9 | ' | 605 |
Total liabilities and shareowners' equity (deficit) | 996.7 | ' | 1,015.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 26.7 | -8.4 | ' |
Capital expenditures | -11.7 | -11 | ' |
Proceeds from sale of assets | 0 | 0 | ' |
Dividends received from CyrusOne | 7.1 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | -4.6 | -11 | ' |
Funding between Parent and subsidiaries, net | -20.6 | 21 | ' |
(Decrease) increase in receivables facility, net | 0 | 0 | ' |
Repayment of debt | -0.7 | -1.5 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | -21.3 | 19.5 | ' |
(Decrease) increase in cash and cash equivalents | 0.8 | 0.1 | ' |
Cash and cash equivalents at beginning of period | 0.3 | 0.3 | ' |
Cash and cash equivalents at end of period | 1.1 | 0.4 | ' |
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | 149.8 | 164.1 | ' |
Operating costs and expenses | 101 | 114.4 | ' |
Operating (loss) income | 48.8 | 49.7 | ' |
Interest expense (income), net | -0.4 | 8.2 | ' |
Other (income) expense, net | -3.1 | -2.7 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 52.3 | 44.2 | ' |
Income tax (benefit) expense | 18.7 | 17 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | ' |
Net income (loss) | 33.6 | 27.2 | ' |
Other comprehensive income (loss) | ' | -0.2 | ' |
Total comprehensive income (loss) | 33.6 | 27 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 33.6 | 27.2 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 1.2 | 1.8 | ' |
Receivables, net | 165.7 | ' | 145 |
Other current assets | 27.3 | ' | 27.3 |
Total current assets | 194.2 | ' | 174.5 |
Property, plant and equipment, net | 709.5 | ' | 708.6 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.3 |
Investments in and advances to subsidiaries | 254.6 | ' | 218.2 |
Other noncurrent assets | 4.6 | ' | 5.1 |
Total assets | 1,165.10 | ' | 1,108.70 |
Current portion of long-term debt | 3.7 | ' | 4.2 |
Accounts payable | 31.8 | ' | 16.1 |
Other current liabilities | 40.3 | ' | 47.1 |
Total current liabilities | 75.8 | ' | 67.4 |
Long-term debt, less current portion | 245.1 | ' | 249.5 |
Other noncurrent liabilities | 169 | ' | 169.9 |
Intercompany payables | 51.9 | ' | 33.2 |
Total liabilities | 541.8 | ' | 520 |
Shareowners' (deficit) equity | 623.3 | ' | 588.7 |
Total liabilities and shareowners' equity (deficit) | 1,165.10 | ' | 1,108.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 41 | 78.2 | ' |
Capital expenditures | -22.6 | -39.9 | ' |
Proceeds from sale of assets | 1.9 | 0.8 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | -12.2 | ' |
Other investing activities | ' | 0.4 | ' |
Cash flows used in investing activities | -20.7 | -50.9 | ' |
Funding between Parent and subsidiaries, net | -16.5 | -45.4 | ' |
(Decrease) increase in receivables facility, net | -1.6 | 2 | ' |
Repayment of debt | -3.2 | -1.6 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | -21.3 | -45 | ' |
(Decrease) increase in cash and cash equivalents | -1 | -17.7 | ' |
Cash and cash equivalents at beginning of period | 2.2 | 19.5 | ' |
Cash and cash equivalents at end of period | 1.2 | 1.8 | ' |
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member] | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) | ' | ' | ' |
Revenue | -14.4 | -14.1 | ' |
Operating costs and expenses | -14.4 | -14.1 | ' |
Operating (loss) income | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | 0 | 0 | ' |
Income tax (benefit) expense | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -38.4 | -15.4 | ' |
Net income (loss) | -38.4 | -15.4 | ' |
Other comprehensive income (loss) | 0 | 0 | ' |
Total comprehensive income (loss) | -38.4 | -15.4 | ' |
Preferred stock dividends | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -38.4 | -15.4 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 |
Other current assets | -0.6 | ' | -0.7 |
Total current assets | -0.6 | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 |
Investments in and advances to subsidiaries | -1,690.50 | ' | -1,623.20 |
Other noncurrent assets | -163.9 | ' | -167.8 |
Total assets | -1,855 | ' | -1,791.70 |
Current portion of long-term debt | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 |
Other current liabilities | 0 | ' | 0.1 |
Total current liabilities | 0 | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 |
Other noncurrent liabilities | -164.5 | ' | -168.6 |
Intercompany payables | -457.3 | ' | -429.5 |
Total liabilities | -621.8 | ' | -598 |
Shareowners' (deficit) equity | -1,233.20 | ' | -1,193.70 |
Total liabilities and shareowners' equity (deficit) | -1,855 | ' | -1,791.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' |
Cash flows (used in) provided by operating activities | 0 | 0 | ' |
Capital expenditures | 0 | 0 | ' |
Proceeds from sale of assets | 0 | 0 | ' |
Dividends received from CyrusOne | 0 | ' | ' |
Cash divested from deconsolidation of CyrusOne | ' | 0 | ' |
Other investing activities | ' | 0 | ' |
Cash flows used in investing activities | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | 0 | 0 | ' |
(Decrease) increase in receivables facility, net | 0 | 0 | ' |
Repayment of debt | 0 | 0 | ' |
Proceeds from exercise of options and warrants | 0 | 0 | ' |
Other financing activities | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | 0 | 0 | ' |
(Decrease) increase in cash and cash equivalents | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | ' |
Various Cincinnati Bell Telephone Notes [Member] | ' | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' | ' |
Debt Instrument, Face Amount | $134.50 | ' | $134.50 |